Narrow search
Showing 1 - 10 of 2,304
Cover Image
Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany
Kuhlmann, Alexander; Schulenburg, Johann-Matthias von der - In: The European journal of health economics : HEPAC ; … 18 (2017) 3, pp. 273-292
Persistent link: https://www.econbiz.de/10011868215
Cover Image
Vaccination Policy, Delayed Care, and Health Expenditures
Aslim, Erkmen Giray; Fu, Wei; Liu, Chia-Lun; Tekin, Erdal - National Bureau of Economic Research - 2022
seeking behavior during a public health crisis. This paper evaluates the effect of COVID-19 vaccination on the individual … eligibility rollout across states and over time as an instrument for individual vaccination status. We find that receiving a COVID … protection against infection. We also find evidence to indicate that vaccination affects healthcare seeking behavior by easing …
Persistent link: https://www.econbiz.de/10013334358
Cover Image
Chapter Eight. Cost Effectiveness and Payment Policy
Garber, Alan M.; Sculpher, Mark J. - In: Handbook of health economics : volume 2, (pp. 471-497). 2011
Cost-effectiveness analysis is versatile and used widely to assist in health care decision making. This chapter discusses how cost-effectiveness analysis is used at the system or national level, particularly in the domain of coverage and payment policy. We describe its relationship to other...
Persistent link: https://www.econbiz.de/10014025580
Cover Image
Investor's behaviour to COVID-19 vaccine : an event study on health and pharmaceutical sector in India
Gupta, Himani; Gupta, Ayushi - In: International journal of pharmaceutical and healthcare … 17 (2023) 4, pp. 429-449
Persistent link: https://www.econbiz.de/10014461499
Cover Image
The Roles of Cost and Recommendations in Driving Vaccine Take-Up : Evidence from the Herpes Zoster Vaccine for Shingles Prevention
Churchill, Brandyn; Henkhaus, Laura - 2022
Vaccination has been called one of the greatest public health success stories, and policymakers have adopted a variety … increase adult vaccination rates – a fact that has been highlighted by the COVID-19 pandemic. Using data from the 2008 …
Persistent link: https://www.econbiz.de/10013300108
Cover Image
Are biopharmaceutical budget caps good public policy?
Goldman, Dana P.; Lakdawalla, Darius; Baumgardner, James R. - In: The Economists' voice 13 (2016) 1, pp. 27-42
Persistent link: https://www.econbiz.de/10011585711
Cover Image
Orphan drugs policies : a suitable case for treatment ; editorial
Drummond, Michael F.; Towse, Adrian - In: The European journal of health economics : HEPAC ; … 15 (2014) 4, pp. 335-340
Persistent link: https://www.econbiz.de/10010360871
Cover Image
Income elasticity of vaccines spending versus general healthcare spending
Alfonso, Y. Natalia; Ding, Guiru; Bishai, David - In: Health economics 25 (2016) 7, pp. 860-872
Persistent link: https://www.econbiz.de/10011542524
Cover Image
Pharmaceutical regulation and health policy objectives
Birg, Laura - 2013
public expenditure, limiting financial exposure of patients, improving access to pharmaceuticals, and stimulating competition …
Persistent link: https://www.econbiz.de/10010224844
Cover Image
Pharmaceutical Cost-Sharing Systems and Savings for Health Care Systems from Parallel Trade
Birg, Laura - 2013
This paper analyzes the consequences of parallel trade on health care systems in a two-country model with a vertical distributor relationship. In particular, two cost-sharing systems coinsurance and indemnity insurance are compared with respect to changes in copayments and public health...
Persistent link: https://www.econbiz.de/10013071665